NTRP:OTCQB-Neurotrope Inc (USD)

COMMON STOCK | Travel Services | OTCQB - U.S. Registered

Last Closing

USD 2.5

Change

-0.08 (-3.10)%

Market Cap

USD 0.14B

Volume

3.57K

Analyst Target

USD 1.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Neurotrope Inc is a development stage company. The Company is a clinical stage biopharmaceutical and diagnostics company, engaged in developing drug candidate called bryostatin and a diagnostic test for Alzheimer's Disease.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Travel Services

Symbol Name Price(Change) Market Cap
BKNG Booking Holdings Inc

+17.02 (+0.43%)

USD 134.76B
ABNB Airbnb Inc

+1.69 (+1.14%)

USD 94.11B
TCOM Trip.com Group Ltd ADR

-1.63 (-3.26%)

USD 33.07B
EXPE Expedia Group Inc.

+2.24 (+1.79%)

USD 16.50B
MMYT MakeMyTrip Limited

-1.63 (-1.98%)

USD 8.96B
TRIP TripAdvisor Inc

-0.18 (-1.00%)

USD 2.51B
LIND Lindblad Expeditions Holdings ..

N/A

USD 0.39B
TOUR Tuniu Corp

-0.06 (-5.73%)

USD 0.13B
YTRA Yatra Online Inc

+0.03 (+2.42%)

USD 0.07B
ISPO Inspirato Inc

-0.13 (-3.47%)

USD 0.01B

ETFs Containing NTRP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Travel Services) Market Performance vs. Exchange (OTCQB - U.S. Registered)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -64.79% 25% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.79% 25% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain -4.70% 53% F 34% F
Dividend Return -4.70% 53% F 32% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.55% 91% A- 67% D+
Risk Adjusted Return -17.71% 46% F 31% F
Market Capitalization 0.14B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Negative earnings

The company had negative total earnings in the most recent four quarters.